Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiaxin Jinhe Investment Management appears to be a China-based investment management firm rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available references indicate it functions as an investment or asset management organization and has been associated with private fund management activities. While it may invest in healthcare or biotech companies, there is no clear evidence that it develops therapeutics, runs a clinical pipeline, or operates as a pharmaceutical or biotechnology company itself. Accordingly, it should be classified as a financial investor, not a healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiaxin Jinhe Investment Management.